ArticleExperimental and therapeutic medicine2021

Rosiglitazone alleviates lipopolysaccharide-induced inflammation in RAW264.7 cells via inhibition of NF-κB and in a PPARγ-dependent manner.

Jing-Ping Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.